Your Article Summary
See Latest ArticlesComplement activation by carotenoid derived aldehydes in cultured human vein epithelial cells
Phytotherapy Research, 05/18/09
Wu P-L et al. - This study was designed to determine the complement activation effects of carotenoid-derived aldehydes (CDA) on cultured human umbilical vein endothelial cells (HUVEC). A dose-dependent complement activation upon incubation of HUVEC with CDA was observed. Interestingly, the data showed that the alternative pathway was not activated. In addition, upon CDA treatment a significant number of apoptotic cells was also observed. The results revealed that CDA could activate the complement by way of the classical pathway. The study suggests that high carotenoid supplementation for the treatment of coronary heart disease should be used cautiously.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
CYP4A11 polymorphism correlates with coronary endothelial dysfunction in patients with coronary artery disease—The ENCORE Trials
Atherosclerosis, 12/04/09
Interleukin-6 promoter polymorphism and cardiovascular risk factors: The Health 2000 Survey
Atherosclerosis, 12/04/09
The -1562C/T MMP-9 promoter polymorphism does not predict MMP-9 expression levels or invasive capacity in saphenous vein smooth muscle cells cultured from different patients
Atherosclerosis, 12/04/09
Today in Complementary Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of the aqueous extract of Salvia Miltiorrhiza (danshen) and its magnesium tanshinoate B-enriched form on blood pressure
Phytotherapy Research, 12/02/09
HMC05, Herbal Formula, Inhibits TNF-alpha-induced Inflammatory Response in Human Umbilical Vein Endothelial Cells
Evidence-based Complementary and Alternative Medicine , 09/14/09
Coenzyme Q10 improves diastolic function in children with idiopathic dilated cardiomyopathy
Cardiology in the Young, 10/19/09